ライフサイエンスコーパス: antihypertensive medication

1 mm Hg, diastolic BP >or= 85 mm Hg, or use of antihypertensive medication).

2 0 mm Hg diastolic (n=10, of whom two were on antihypertensive medications).

3 blood pressure >/=90 mm Hg, or initiation of antihypertensive medications).

4 adequate blood pressure control were CHD and antihypertensive medication.

5 ic BP level of 90 mm Hg or higher, or use of antihypertensive medication.

6 mm Hg, diastolic BP >/= 90 mm Hg, or use of antihypertensive medication.

7 pressure of at least 90 mm Hg, or use of an antihypertensive medication.

8 an 140 mm Hg at 6 months; intensification of antihypertensive medication.

9 group developed a requirement for additional antihypertensive medication.

10 ambulatory visit received an order for a new antihypertensive medication.

11 to ensure patient compliance with absence of antihypertensive medication.

12 overt cardiovascular disease, and no use of antihypertensive medication.

13 intensive BP lowering for many adults taking antihypertensive medication.

14 intensive BP lowering for many adults taking antihypertensive medication.

15 133 mm Hg, respectively, among those taking antihypertensive medication.

16 s and 85 patients (75.9%) were taking ocular antihypertensive medications.

17 determine history of hypertension and use of antihypertensive medications.

18 biennially updated data on hypertension and antihypertensive medications.

19 lic BP, female sex, anemia, and use of other antihypertensive medications.

20 BP >/=80 mm Hg or with self-reported use of antihypertensive medications.

21 d, coupled with significantly greater use of antihypertensive medications.

22 icacy of renal denervation in the absence of antihypertensive medications.

23 unt to choose adequate immunosuppressive and antihypertensive medications.

24 ed incidence of diabetes compared with other antihypertensive medications.

25 cident diabetes that develops while on other antihypertensive medications.

26 th incident hypertension who were started on antihypertensive medications.

27 Disease (PREVEND) study who were not taking antihypertensive medications.

28 on (aTRH) when subjects reported taking >/=3 antihypertensive medications.

29 e in association with five common classes of antihypertensive medications.

30 herally acting drug amlodipine and for other antihypertensive medications.

31 afely lower blood pressure in the absence of antihypertensive medications.

32 e hypertension in the presence or absence of antihypertensive medications.

33 compared with infants who had no exposure to antihypertensive medications.

34 -reported history of hypertension and use of antihypertensive medications.

35 d pressure of 90 mm Hg or greater, or taking antihypertensive medications.

36 ressure of 90 mm Hg or higher, or the use of antihypertensive medications.

37 success was defined as IOP <=21 mmHg without antihypertensive medications.

38 lic blood pressure > or =90 mm Hg, or taking antihypertensive medications.

39 lower blood pressures and the need for fewer antihypertensive medications.

40 of blood pressure, as well as on evaluating antihypertensive medications.

41 microbiome modulates response to statins and antihypertensive medications.

42 to explore the efficacy and side effects of antihypertensive medications.

43 am procedure among patients not treated with antihypertensive medications.

44 ients exhibited poor adherence to prescribed antihypertensive medications.

45 tients were drug-naive or discontinued their antihypertensive medications.

46 ervation on blood pressure in the absence of antihypertensive medications.

47 the availability, cost, and prescription of antihypertensive medications.

48 Patients were withdrawn from antihypertensive medications 1 to 2 weeks before enrollm

49 to an increased uptake of treatments, mainly antihypertensive medication (12%) and initial treatments

50 lled 64 otherwise healthy patients taking no antihypertensive medications (31% women, 42% black, age

51 Among U.S. adults taking antihypertensive medication, 53.4% (95% CI: 49.9% to 56.

52 Among US adults taking antihypertensive medication, 53.4% (95% CI: 49.9% to 56.

53 Among older patients treated with multiple antihypertensive medications, a strategy of medication r

54 ith hypertension who are not recommended for antihypertensive medication according to the 2017 ACC/AH

55 ith hypertension who are not recommended for antihypertensive medication according to the 2017 ACC/AH

56 for PM2.5 mass, age, body mass index, use of antihypertensive medication (ACE inhibitors, non-ophthal

57 Use of 2 or more antihypertensive medications, ACEI, and diuretics were a

58 he mechanism by which the various classes of antihypertensive medications achieve their effect, it re

59 ined the association between life events and antihypertensive medication adherence in older adults an

60 iews the effectiveness of methods to improve antihypertensive medication adherence, discusses the eff

61 evel on HT awareness, treatment, control, or antihypertensive medication adherence.

62 al, psychological, and biologic variables on antihypertensive medication adherence.

63 ypertension without further need of lifelong antihypertensive medications after adrenalectomy for ald

64 Lowering high blood pressure with specific antihypertensive medications (AHMs) could reduce the bur

65 The presence of structural abnormalities or antihypertensive medication also correlated statisticall

66 Use of antihypertensive medications among patients with a histo

67 ension control was defined as treatment with antihypertensive medication and a measured blood pressur

68 The use of antihypertensive medication and hypertension control has

69 ociation between initiating and intensifying antihypertensive medication and serious fall injuries in

70 proportion of individuals with resistance to antihypertensive medication and/or poor compliance or to

71 3362 sites, 8.1% (95% CI 7.2-9.1) stocked no antihypertensive medications and 33.8% (32.2-35.4) stock

72 Hg after a 4-week discontinuation of up to 2 antihypertensive medications and a suitable renal artery

73 tigation, as do associations between certain antihypertensive medications and death.

74 am group (p=0.008) and the average number of antihypertensive medications and defined daily dose were

75 cipants in the low target groups needed more antihypertensive medications and had a slightly higher r

76 oring was most effective in those with fewer antihypertensive medications and higher baseline sBP up

77 cal condition, thus discounting the value of antihypertensive medications and interfering with medica

78 The effect of antihypertensive medications and lowering sodium intake

79 for 4 medical exposures (oestrogen, statin, antihypertensive medications and non-steroidal anti-infl

80 e of comorbid conditions, and current use of antihypertensive medications and nonsteroidal anti-infla

81 patients (57.7%) were completely weaned-off antihypertensive medications and their use dropped from

82 ssure of at least 140/90 mm Hg or the use of antihypertensive medication) and subjects without hypert

83 betes, 54% had hypertension (47% were taking antihypertensive medications), and 60% had hyperlipidemi

84 (or 85 to 105 mm Hg if the woman was taking antihypertensive medications), and a live fetus.

85 d drug treatment: 86% used statins, 90% used antihypertensive medication, and 98% used antithrombotic

86 They also received more antihypertensive medication, and a greater proportion re

87 ed diagnosis of hypertension, current use of antihypertensive medication, and blood pressure of less

88 duration, smoking, systolic blood pressure, antihypertensive medication, and BMI.

89 d pressure (BP) thresholds for initiation of antihypertensive medication, and BP target goals.

90 he percentage of U.S. adults recommended for antihypertensive medication, and more intensive BP lower

91 the percentage of US adults recommended for antihypertensive medication, and more intensive BP lower

92 tension, implications of recommendations for antihypertensive medication, and prevalence of BP above

93 tension, implications of recommendations for antihypertensive medication, and prevalence of BP above

94 atment received an average of one additional antihypertensive medication, and the systolic blood pres

95 is, 30.1% (30.0-30.2) were taking prescribed antihypertensive medications, and 7.2% (7.1-7.2) had ach

96 ibodies, discontinuation of antiplatelet and antihypertensive medications, and any increase of 1 trad

97 nd regional estimates of current coverage of antihypertensive medications, and cause-specific mortali

98 3 levels were more likely White race, taking antihypertensive medications, and had lower kidney funct

99 the effect of differential cotreatment with antihypertensive medications, and long lag time to clini

100 Information on hypertension history, use of antihypertensive medications, and potential confounders

101 ted for conventional AF risk factors, use of antihypertensive medications, and serum potassium.

102 n of examination, state of residence, use of antihypertensive medications, and smoking status.

103 PP, duration of diabetes, gender, number of antihypertensive medications, and use of angiotensin-con

104 BP >=80 mm Hg with use of 1 to 2 classes of antihypertensive medication; and resistant BP as systoli

105 ts with high blood pressure (BP) do not have antihypertensive medications appropriately intensified a

106 Older age, lower registration LVEF, and antihypertensive medications are associated with increas

107 Several antihypertensive medications are commercially available

108 ontinuation of gemcitabine, the provision of antihypertensive medications as needed, and consideratio

109 ars (nearly a quarter of program spending on antihypertensive medications), as well as being more cli

110 s with prevalent CV disease and those taking antihypertensive medication at baseline.

111 of participants with diabetes were receiving antihypertensive medication at recruitment and 1% were r

112 ility, cost, and prescription patterns of 62 antihypertensive medications at primary health-care site

113 130 to 180 mm Hg (depending on the number of antihypertensive medications being taken), and high card

114 e found that participants taking any type of antihypertensive medication (beta = -0.83; 95% confidenc

115 oxytyramine, by preventing interference from antihypertensive medication (beta-blockers).

116 lts with hypertension, differences in use of antihypertensive medications between continuously uninsu

117 n weight, serum cholesterol, and (along with antihypertensive medication) blood pressure reduced the

118 our readily available predictors (2 or fewer antihypertensive medications, body mass index < or =25 k

119 tolic blood pressure <80 mm Hg and not using antihypertensive medications, body mass index <25 kg/m(2

120 130 to 180 mm Hg depending on the number of antihypertensive medication classes being taken, and hig

121 f US hypertensive adults took a prescription antihypertensive medication compared with 57.3% during 1

122 with less requirement for lipid-lowering and antihypertensive medication compared with cyclosporine,

123 ease, self-monitoring with self-titration of antihypertensive medication compared with usual care res

124 maintained at 6 months with less prescribed antihypertensive medications compared with a sham contro

125 We sought to determine whether antihypertensive medications could be used more effectiv

126 Antihypertensive medication data were obtained from all

127 le score (age, sex, systolic blood pressure, antihypertensive medication, diabetes mellitus, cigarett

128 ent smoking, systolic blood pressure, use of antihypertensive medication, diabetes mellitus, serum po

129 physical activity, systolic blood pressure, antihypertensive medications, diabetes mellitus, diabeti

130 Use of antihypertensive medication did not modify the relations

131 In contrast, fetal exposure to other antihypertensive medications during only the first trime

132 variant was associated with modification of antihypertensive medication effects on cardiovascular di

133 s have an elevated risk of hypertension, and antihypertensive medications, especially beta-blockers,

134 Antihypertensive medications evaluated included beta-blo

135 who fail to take their prescribed statin and antihypertensive medication experience a substantially i

136 Current guidelines for prescribing antihypertensive medications focus on reaching specific

137 We screened 55 clinically prescribed antihypertensive medications for AD-modifying activity u

138 Act has led to the study and approval of new antihypertensive medications for use in pediatrics.

139 olution of hypertension without the need for antihypertensive medications from patients that will req

140 Owing to the widespread use of antihypertensive medications, global mean blood pressure

141 Children on antihypertensive medication had impaired physical functi

142 mpared with controls, participants receiving antihypertensive medications had a pooled relative risk

143 To date, no specific antihypertensive medications have been shown to be more

144 yet only about 50% of patients treated with antihypertensive medications have their blood pressure c

145 Key secondary outcomes were number of antihypertensive medications, hypertension remission, an

146 n to lower blood pressure with >/=1 class of antihypertensive medication identified through a pill bo

147 ystolic blood pressure in subjects not using antihypertensive medication in unadjusted (133.7+/-20.7

148 led more than 2.05 million prescriptions for antihypertensive medications in 2001, at an annual progr

149 rn preterm were more likely to be prescribed antihypertensive medications in 2005-2009 than those bor

150 t current patterns of access to, and use of, antihypertensive medications in Chinese primary health c

151 t that there are differences in adherence to antihypertensive medications in different classes.

152 ugh few data exist on efficacy and safety of antihypertensive medications in neonates, a wide variety

153 espite the greater use of lipid-lowering and antihypertensive medications in the cyclosporine group.

154 er alone, 202 infants with exposure to other antihypertensive medications in the first trimester alon

155 The need for antihypertensive medications in two of these seven poten

156 e of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the interventi

157 The most commonly used antihypertensive medications included diuretics, angiote

158 BP >=80 mm Hg with the use of >=3 classes of antihypertensive medication (including a diuretic) or us

159 njury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36

160 ilable on the short-term risk of falls after antihypertensive medication initiation and intensificati

161 Antihypertensive medication initiation and intensificati

162 scular disease was a novel consideration for antihypertensive medication initiation in the 2017 Ameri

163 Antihypertensive medication initiation was defined by a

164 erence and treatment intensification (TI) of antihypertensive medications is associated with blood pr

165 on (RHT) although nonadherence to prescribed antihypertensive medications is common in patients with

166 patients that will require continued use of antihypertensive medications is difficult before adrenal

167 ave reported that blood pressure response to antihypertensive medications is influenced by genetic va

168 Patient adherence to antihypertensive medications is not associated with BP c

169 Deprescribing of antihypertensive medications is recommended for some old

170 plant recipients receiving ACEI/ARB or other antihypertensive medications is virtually identical.

171 k, education on hypertension, prescribing of antihypertensive medications, laboratory monitoring, and

172 ormed in 3935 subjects who were not using an antihypertensive medication, lipid-lowering drugs, or a

173 cular disease event reduction) approaches to antihypertensive medication management.

174 epidemiological evidence suggests that some antihypertensive medications may reduce the risk for Alz

175 d with higher blood pressure, such as use of antihypertensive medications--may reduce AD risk.

176 A total of 101 (85%) patients were receiving antihypertensive medications (median 2), and 85 (71%) ac

177 bject with severe hypertension refractory to antihypertensive medications, monotherapy with NO supple

178 e at follow-up, as defined as treatment with antihypertensive medications (n=8) or average blood pres

179 netics and pharmacodynamics of the different antihypertensive medications need to be carefully consid

180 blood pressure 120/</=80 mm Hg and no use of antihypertensive medication; no current smoking; and no

181 Antihypertensive medication nonadherence and the white c

182 sradipine, a general LTCC antagonist used as antihypertensive medication, not only blocks the inducti

183 Antihypertensive medication number and percentages on >/

184 nfidence interval: 2.15-17), and about their antihypertensive medications (odds ratio: 6.48; 95% conf

185 ombination of at least three optimally dosed antihypertensive medications, one of which is a diuretic

186 Prevalent hypertension was defined as taking antihypertensive medication or having systolic blood pre

187 Hypertensive status was defined as use of antihypertensive medication or measured BP > or =140/90

188 eneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 1

189 ected differentially by different classes of antihypertensive medications or treatment with statins.

190 >=130 mm Hg or diastolic BP >80mm Hg, use of antihypertensive medication, or self-report of a diagnos

191 P of at least 90 mm Hg, self-reported use of antihypertensive medications, or both.

192 tricted to those with hypertension or taking antihypertensive medications: OR = 4.20 (95% CI: 1.28 to

193 ssure less than 90 mm Hg who were not taking antihypertensive medications, oral hypoglycemic medicati

194 Use of antihypertensive medication other than diuretic agents w

195 dex included systolic BP, anemia, and use of antihypertensive medications other than angiotensin-conv

196 sociated with a higher probability of taking antihypertensive medication (p = 6.7 x 10(-8)).

197 ne or more adjustments of insulin (P=0.006), antihypertensive medications (P<0.001), and antidepressa

198 with hypertension despite taking at least 1 antihypertensive medication, paroxysmal atrial fibrillat

199 e clear guidelines and an array of available antihypertensive medications, patients with hypertension

200 will need to improve access to, and use of, antihypertensive medications, paying particular attentio

201 , 84.8 years; 276 [48.5%] women; median of 2 antihypertensive medications prescribed at baseline), 53

202 rn preterm had an increased relative rate of antihypertensive medication prescription that increased

203 s, underlying medical conditions, outpatient antihypertensive medications, recorded symptoms, vital s

204 pressure, cholesterol concentration, use of antihypertensive medication, recreational exercise, non-

205 ealthy patients up to age 85 years with most antihypertensive medications reduces cardiovascular morb

206 were randomized (1:1 ratio) to a strategy of antihypertensive medication reduction (removal of 1 drug

207 The findings suggest antihypertensive medication reduction in some older pati

208 This study aimed to establish whether antihypertensive medication reduction is possible withou

209 cluding a diuretic) or use of >=4 classes of antihypertensive medication regardless of BP level.

210 ine, mean blood pressure, and mean number of antihypertensive medications required before and after c

211 acceptable patient BP control and minimizing antihypertensive medication requirements.

212 60.1-76.0) among those taking and not taking antihypertensive medication, respectively.

213 and 10% (7-13%) among nonusers and users of antihypertensive medications, respectively.

214 95% CI, 0.959-0.977), number of preoperative antihypertensive medications (RYGB: OR, 0.104; 95% CI, 0

215 Patients on antihypertensive medication seem to be the most vulnerab

216 c characteristics (age, sex, income); use of antihypertensive medication; smoking; tooth loss; dental

217 d as either new diagnosis, the initiation of antihypertensive medication, systolic blood pressure > o

218 nt was both more effective and required less antihypertensive medication than current guidelines base

219 hypertension were still less likely to take antihypertensive medication than non-Hispanic whites wit

220 scular deficits in AD.SIGNIFICANCE STATEMENT Antihypertensive medications that target the renin angio

221 Among participants taking antihypertensive medication, the regression-derived thre

222 Among participants not taking antihypertensive medication, the regression-derived thre

223 tion of one of the most effective classes of antihypertensive medications, thiazide diuretics.

224 Patients were to remain off antihypertensive medications throughout the first 2 mont

225 Increasing coverage of antihypertensive medications to 70% alone would delay 39

226 nts with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90

227 imely initiation and subsequent titration of antihypertensive medications to achieve individualised B

228 large number of patients continue to require antihypertensive medications to control their blood pres

229 stolic blood pressure >/=90 mm Hg, or use of antihypertensive medications to treat high blood pressur

230 itating improvements in patient adherence to antihypertensive medications, to provide a framework for

231 everity, background hypertension prevalence, antihypertensive medication treatment, case fatality, in

232 art disease and stroke risk reduction due to antihypertensive medication treatment.

233 Men had the greatest increase in antihypertensive medication use (47.5%, 1988-1994 versus

234 n uncontrolled blood pressure, and continued antihypertensive medication use (medication adherence ra

235 cigarettes smoked (P for trend < 0.001), and antihypertensive medication use (P < 0.001).

236 This study examined trends in prescribed antihypertensive medication use among US adults with hyp

237 Antihypertensive medication use and multiple antihypertensive medication use among US hypertensive ad

238 Antihypertensive medication use and blood pressure contr

239 f this study was to examine recent trends in antihypertensive medication use and its impact on blood

240 onducted to estimate the association between antihypertensive medication use and markers of increased

241 Antihypertensive medication use and multiple antihyperte

242 asting insulin concentrations, diabetes, and antihypertensive medication use but became nonsignifican

243 Antihypertensive medication use has been associated with

244 The adjusted associations between antihypertensive medication use in aggregate and 3 or mo

245 e, beta-blocker, ACE-inhibitor, diuretic, or antihypertensive medication use in aggregate remained as

246 icant decrease in systolic blood pressure or antihypertensive medication use in the patients receivin

247 ssure of at least 90 mm Hg, or self-reported antihypertensive medication use in the previous 2 weeks.

248 of diabetes mellitus, history of stroke, and antihypertensive medication use increased at higher low-

249 The prevalence of antihypertensive medication use increased from 63.5% in

250 In both surveys, antihypertensive medication use increased with age, was

251 n emergency department anaphylaxis patients, antihypertensive medication use is associated with incre

252 ts with at least a 50% reduction in baseline antihypertensive medication use lasting at least 6 mo.

253 Antihypertensive medication use rose to >50% among all a

254 iastolic dimensions with increasing age; and antihypertensive medication use was a marker of an atten

255 Antihypertensive medication use was self-reported.

256 , body mass index, blood pressure (including antihypertensive medication use), smoking, and diabetes

257 BP> or =140 or diastolic BP> or =90 mm Hg or antihypertensive medication use).

258 ng for age, randomized treatment assignment, antihypertensive medication use, and coronary risk facto

259 lcohol consumption, systolic blood pressure, antihypertensive medication use, diabetes mellitus, and

260 olic blood pressure, current smoking status, antihypertensive medication use, diabetes mellitus, hist

261 ressure, fasting glucose, total cholesterol, antihypertensive medication use, glomerular filtration r

262 rs, including age, body mass index, smoking, antihypertensive medication use, or C-reactive protein l

263 , and sex), traditional stroke risk factors (antihypertensive medication use, systolic blood pressure

264 , sex, tobacco use, systolic blood pressure, antihypertensive medication use, total and high-density

265 ies, body mass index, SBP, diastolic BP, and antihypertensive medication use.

266 body mass index, vascular risk factors, and antihypertensive medication use.

267 16%-37%) had a durable reduction in baseline antihypertensive medication use.

268 Analyses were stratified by antihypertensive medication use.

269 ased on average blood pressure >/=140/90 and antihypertensive medication use.

270 In replication, baseline antihypertensive medication users in the supplementation

271 The lifetime probability of receiving antihypertensive medication was 60%.

272 A pharmacometabolomics study of antihypertensive medication was conducted and data were

273 Low adherence to antihypertensive medication was defined as scores less t

274 ctorial intervention to improve adherence to antihypertensive medication was effective in improving b

275 (95% CI: 30.1% to 33.7%), respectively, and antihypertensive medication was recommended for 36.2% (9

276 (95% CI: 30.1% to 33.7%), respectively, and antihypertensive medication was recommended for 36.2% (9

277 In a separate analysis, the use of antihypertensive medications was independently associate

278 Use of a greater number of antihypertensive medications was significantly associate

279 = 26) at 12 months, p < 0.01; the number of antihypertensive medications was significantly lower in

280 ic ethnicity and requirement for more than 1 antihypertensive medication were independently associate

281 Significant predictors of receiving antihypertensive medication were: increasing age, female

282 registration LVEF less than 65%, and use of antihypertensive medications were associated with an inc

283 Blood pressure measurements and all antihypertensive medications were determined for both gr

284 Antihypertensive medications were discontinued before st

285 han 150 mm Hg, and were receiving at least 2 antihypertensive medications were included.

286 on (blood pressure > or =140/90 mm Hg or new antihypertensive medication) were calculated.

287 ion, defined as BP >= 140/90 mm Hg or taking antihypertensive medication, were advised to visit a doc

288 h pre- or stage 1 hypertension and not using antihypertensive medications, were randomized to either

289 at least a 30% reduction in total number of antihypertensive medications while maintaining BP less t

290 Reduction of >/=30% of the total number of antihypertensive medications while maintaining controlle

291 s reduction of >/=30% of the total number of antihypertensive medications while maintaining systolic

292 r hypertension not currently recommended for antihypertensive medication who are at high risk for CV

293 ge 1 or stage 2 hypertension recommended for antihypertensive medication with BP <160/100 mm Hg, thos

294 were used to investigate the association of antihypertensive medication with OCT measurements of RNF

295 Among participants taking antihypertensive medication with SBP/DBP <140/90 mm Hg,

296 vated BP or hypertension not recommended for antihypertensive medication with versus without either e

297 sociation of prior existing hypertension and antihypertensive medications with risk of incident psori

298 ontrolled blood pressure despite use of >/=3 antihypertensive medications, with data collected on pre

299 .6%) FMD patients have subsequently required antihypertensive medications, with one requiring angiopl

300 The adjusted odds ratio for >/=1 antihypertensive medications/year ranged from 1.25 (95%